Literature DB >> 2566458

Displacement of bilirubin from adult and newborn serum albumin by a drug and fatty acid.

R Ivarsen1, R Brodersen.   

Abstract

Competitive binding of bilirubin and 5-butyl-1-cyclohexylbarbituric acid (bucolome) to human serum albumin was investigated by equilibrium dialysis, with and without added bilirubin (0.5 mol/mol albumin). Further observations were made by peroxidase oxidation kinetics. Finally, cobinding of the two ligands was studied by spectrophotometry. Experiments were performed with defatted adult human serum albumin, with umbilical cord serum, and with adult albumin to which was bound 2 mol palmitate/mol albumin. Bucolome does not induce displacement of bilirubin from binding to defatted adult albumin when one molecule of either ligand is bound. The second molecule of bound bucolome displaces the first bilirubin molecule. With albumin in umbilical cord serum, the first bucolome does decrease binding of the first bilirubin to some extent although the two ligands can bind to the same albumin molecule. The presence of two molecules of bound palmitate together with one of bilirubin causes enhanced bilirubin displacement on binding of bucolome. These observations may be of consequence for practical testing of the bilirubin displacing effect of drugs. Experiments with neonatal albumin and with added fatty acid should be included for a complete study.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2566458

Source DB:  PubMed          Journal:  Dev Pharmacol Ther        ISSN: 0379-8305


  6 in total

Review 1.  Lipid injectable emulsions: Pharmacopeial and safety issues.

Authors:  David F Driscoll
Journal:  Pharm Res       Date:  2006-08-09       Impact factor: 4.200

2.  Management of hyperbilirubinemia and prevention of kernicterus in 20 patients with Crigler-Najjar disease.

Authors:  Kevin A Strauss; Donna L Robinson; Hendrik J Vreman; Erik G Puffenberger; Graham Hart; D Holmes Morton
Journal:  Eur J Pediatr       Date:  2006-01-25       Impact factor: 3.183

Review 3.  The role of the protein-binding on the mode of drug action as well the interactions with other drugs.

Authors:  Christine Tesseromatis; Anastasia Alevizou
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2008 Oct-Dec       Impact factor: 2.441

4.  Stress can affect drug pharmacokinetics via serum/tissues protein binding and blood flow rate alterations.

Authors:  Kotsiou Antonia; Alevizou Anastasia; Christine Tesseromatis
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2011-12-16       Impact factor: 2.441

5.  Influence of clinical status on the association between plasma total and unbound bilirubin and death or adverse neurodevelopmental outcomes in extremely low birth weight infants.

Authors:  W Oh; D K Stevenson; J E Tyson; B H Morris; C E Ahlfors; G Jesse Bender; R J Wong; R Perritt; B R Vohr; K P Van Meurs; H J Vreman; A Das; D L Phelps; T Michael O'Shea; R D Higgins
Journal:  Acta Paediatr       Date:  2010-01-25       Impact factor: 2.299

6.  Macromolecular and Solution Properties of the Recombinant Fusion Protein HUG.

Authors:  Paola Sist; Antonella Bandiera; Ranieri Urbani; Sabina Passamonti
Journal:  Biomacromolecules       Date:  2022-07-25       Impact factor: 6.978

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.